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Abstract 
The relationship between the molecular structures of corn bran 
arabinoxylans (AXs) and their immune-modulating activities (the 
structure-activity relationship) was investigated. This study extracted AXs from 
corn bran using alkaline and developed AXs modification process using three 
types of endoxylanases from Thermomyces lanuginosus, Neocallimastix 
patriciarum and Penicillium funiculosum. Furthermore, the non-modified and 
modified AXs with different molecular structures were investigated with respect 
to their ability to modulate nitric oxide (NO) production in vitro as an indication 
of their immunomodulatory potential.  
From the corn bran, using alkaline treatment, the recovery rate of AX was up 
to 80% (dry matter basis) of total corn bran AX and the Mw distribution of 
extracted AXs was in the high Mw range (100KDa to 794KDa). Following 
enzymatic modification, more than 30% of AXs extracted were reduced to the 
lower Mw range (0.1KDa to 10KDa). In vitro studies showed that the extracted 
and modified AXs significantly elevated the level of NO synthesis by human U937 
cells (p<0.05). The results also indicated there was an obvious dose-response 
effect for each of AX samples but the effective range over which they work is 
different. Modified AXs with higher portion of low Mw showed a significant 
lower optimum dose range than extracted AXs with higher portion of high Mw 
(p<0.05). The study suggested that the Mw distribution of AX is a determinant 
for their optimum dose on NO production by macrophage, thereby affects its 
immune-modulatory activity.  
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Introduction 
Immune system plays a pivotal role in the protection and maintenance of 
human health (National Institutes of Health 2003). However, multiple factors 
such as genetic predisposition, malnutrition, aging, mental stress or undesirable 
lifestyles can disturb human immune functions (Gleeson 2005; Hughes 1999; Ibs 
and Rink 2003; Lomax and Calder 2009; O'Leary 1990; Plat and Mensink 2005; 
Webster Marketon and Glaser 2008). Therefore, the ingestion of foods and 
food-derived substances with immune-modulating activities is widely studied. 
Further dietary intervention is considered an efficient way of preventing immune 
functions from declining and reducing the risk of infection or cancer (Canter and 
Ernst 2004; Cassileth et al. 2009; Kaminogawa and Nanno 2004; Meoni et al. 
2013). Some dietary fibre-derived substances, such as β-1,3-glucan, β-1,6-glucan 
and α-1,6-mannan, have been discovered that show immune stimulation activity 
(Brown and Gordon 2003; Rieder et al. 2011; Tzianabos 2002; Volman et al. 
2008). It has also been proposed that AXs are potent functional food 
supplements due to modulating both the innate and adaptive immune systems 
(Ghoneum and Jewett 2000; Ghoneum and Matsuura 2004; S. Zhang et al. 2015). 
For instance, there is a modified AX with small Mw (<50KDa) from rice bran, also 
called MGN-3/Biobran, a commercial product of cereal AXs that has been tested 
for its immune enhancing effects on the immune system by in vitro assays and in 
vivo animal/human studies (Cholujova et al. 2009; Ghoneum 1998a; Ghoneum 
and Jewett 2000; Ghoneum and Matsuura 2004; Ghoneum and Abedi 2004; 
Ghoneum et al. 2004; Ghoneum and Gollapudi 2005; Ghoneum et al. 2008).  
Recently, some papers have shown interest in the relationship between the 
bioactivity of AX and its molecular structural properties, including molecular 
weight, degree of branching and sugar compositions (Zhou et al. 2010; W. Li et al. 
2015; S. Zhang et al. 2015). The AXs extracted from wheat bran via alkaline (large 
Mw: 350KDa) and enzyme (low Mw: 33KDa) both showed stimulating effects on 
the immune response in vivo. The low Mw AXs showed a higher level of 
macrophage phagocytosis than the large Mw AXs (Zhou et al. 2010). More 
recently, it has been reported by Li et al. (2015) that enzyme extracted AXs from 
the pentosan of wheat flour have greater immune stimulation activities in vitro 
testing than water extracted AXs. This difference in bioactivity may associated 
with the enzyme extracted AX having a higher portion of lower Mw (≤25KDa) 
and higher degree of branching (0.81). This study also suggested that further 
investigation need to determine whether it is the difference in Mw distribution 
or the difference in the degree of branching or a combination of these, which 
produced the relatively high stimulatory activity of the enzyme treated AXs (W. Li 
et al. 2015). The structures of AXs vary in Mw, degree of branching, substitutions 
and conformation (Izydorczyk and Biliaderis 2007). However, there has been no 
clear consensus as to which main molecular structural properties are required 
for AXs to confer their immune-modulating ability. Thus, the mechanisms of the 
structure-activity relationship of AXs still remain to be studied.  
Cereal brans were found to be cost effective sources of AXs, which are 
by-products of cereal processing (Izydorczyk and Biliaderis 2007). As a result of 
their high Mw and high ferulic acid content AXs readily form 
covalent/non-covalent linkages between AXs chains and with other components 
of the cell wall such as proteins, β-glucans, lignin and cellulose, hence a high 
proportion of AXs cannot be extracted using water (Beaugrand et al. 2004b; 
Saulnier et al. 2007). Therefore, various methods have been developed for the 
extraction and purification of AXs from cereal by-products, including alkaline and 
acid extraction (Höije et al. 2005; Hollmann and Lindhauer 2005; Zhou et al. 
2010), enzyme hydrolysis (Beaugrand et al. 2004c; W. Li et al. 2013; Maes et al. 
2004), microwave-assisted extraction (Rose and Inglett 2010), 
ultrasound-assisted extraction (Z. Ebringerova et al. 1998; Hromadkova et al. 
1999), steam explosion extraction (Allen et al. 2001), hot compressed water 
extraction (Dien et al. 2006), twin-screw extrusion extraction (Marechal et al. 
2004; Zeitoun et al. 2010), ethanol purification and ammonium sulphate 
precipitation (Izydorczyk and Biliaderis 2007). It has been found that the 
extraction yields and molecular characteristics of AXs vary depending upon the 
extraction and modification methods used (Z. Zhang et al. 2014). Corn bran has 
also been identified to be a cereal source with a high AXs content (25-30%) and 
the extraction methods for this material have also been studied (L.W. Doner and 
Hicks 1997a; L.W. Doner et al. 1998). However, there is limited data exists on 
corn bran AX’s immunomodulatory properties.   
Enzyme hydrolysis is an efficient method for modifying the molecular 
structure of AXs (Z. Zhang et al. 2014). Endoxylanases and cellulases are 
commonly used to extract and degrade AXs from cereal cell wall tissue. 
Endo-β-1,4-xylanases (EC 3.2.1.8) are the hemicellulolytic enzymes, which cleave 
the β-xylosidic bond between two d-xylopyranosyl residues linked in β-(1,4) 
(Paes et al., 2012; Driss et al., 2013). Endo-β-xylanases (EC 3.2.1.8) are mainly 
classified into two glycoside hydrolase (GH) families namely GH 10 and GH 11. 
Endoxylanases from the GH11 family are commonly used to hydrolysis 
microstructure of AXs because of their higher substrate specificity than GH 10 
endoxylanases (Beaugrand et al., 2004;Driss et al., 2013). Three GH family 11 
endoxylanases from Thermomyces lanuginosus, Neocallimastix patriciarum and 
Penicillium funiculosum have been characterised and have been used in different 
studies for isolation and modification of cereal hemicellulose (Elshafei et al., 
1991; Zhou et al., 2010; Li et al., 2015; Malunga and Beta, 2015). However, the 
effects of these three enzyme modification processes on the molecular structures 
of the corn bran AXs have not well documented. Thus, this investigation aims to 
develop extraction and enzyme modification processes for modifying the 
molecular structures of AXs from corn bran. The monosaccharide compositions, 
branch degree and Mw distribution of the extracted and modified AXs were 
determined using high performance liquid chromatography (HPLC). 
Subsequently, the relationship between molecular structure and 
immune-modulating activity of the AXs in vitro are investigated.  
1 Materials and Methods 
1.1. Materials 
Corn bran is a by-product of corn starch processing (M.P. Yadav et al. 2007). 
In the current study, the sample of dried corn bran (moisture content 4.5%) was 
kindly provided from Chinese Academy of Agriculture Sciences (Beijing, China). 
There were three endo-1,4-β-xylanase products (EC 3.1.2.8) used in the 
modification of AXs, which were Pentopan Mono BG (P-BG, 2500 u/g) from 
Thermomyces lanuginosus (Novozyme, Bagsvaerd, Denmark), E-XYLNP 
(1000-1500 u/mg) from Neocallimastix patriciarum (Megazyme, Bray, Wicklow 
Ireland) and Optimash VR (O-VR, 3150 u/g) from Penicillium funiculosum 
(Genencor, Leiden, Netherland). 1,4-α-D-Glucan-glucanohydrolase (a-Amylase 
heat stable, ≥500 u/ml) from Bacillus licheniformis and Proteinase (≥500 u/ml) 
from Aspergillus melleus were purchased from Sigma-Aldrich, Gillingham, United 
Kingdom.  
D-(+)-xylose for AXs extraction yield determination was purchased from 
Acros Organics (Loughborough, UK). Eight pullulan (without side chains) 
standards of varying molecular weights (5–800KDa) were purchased from 
Shodex (Shanghai, China). D-glucose, D-xylose, D-arabinose, and D-galactose 
were purchased from Sigma–Aldrich (Gillingham, UK).   
Human macrophage cell line U937 is derived from malignant cells from a 
pleural effusion from a 37-year-old caucasian male with diffuse histiocytic 
lymphoma (Sundstrom and Nillon 1976). U937 grows in suspension in 
conventional culture. U937 cells were purchased from the Public Health England 
Culture Collections. LPS (Lipopolysaccharides of E. coli serotype O111:B4, Sigma 
Aldrich, UK) was used as a positive control in the nitric oxide (NO) stimulation 
assay. RPMI-1640 medium with L-Glutamine purchased from Lonza (Verviers, 
Belgium). Foetal bovine serum and penicillin-streptomycin (10,000 units 
penicillin and 10mg streptomycin/ml) were purchased from Sigma-Aldrich 
(Gillingham, USA).  
Other chemicals including acids, alkaline and organic solvents were 
purchased from Sigma Aldrich, UK and used were of analytical grade.  
 
2.2 Methods 
2.2.1 Extraction and purification process of arabinoxylans from corn bran 
Alkaline extraction of AXs from corn bran using a method developed from 
L.W. Doner and Hicks (1997a) and L.W. Doner et al. (1998). Milled corn bran 
(300g) was mixed in 2000g of distilled water (1.5:10, w/w) using a hand blender 
(800W, WSB800U) for 45s. The pH of the mixture was adjusted to 7.0. 780µl 
Termamyl α-amylase was added into the mixture, which then treated in a 90°C 
shaking (100 r/min) water bath for 1h. Then, the mixture was boiled for 15 min 
to inactivate the enzyme. The mixtures were cooled rapidly under cold water 
followed by centrifugation (6000g, 20min), and the residue was recovered and 
placed in an oven overnight at 45°C for drying. Dried residue was collected to 
obtain de-starched corn bran. 
De-starched corn bran samples (60g) was mixed in 600g of distilled water 
(1:10, w/w) using a hand blender (800W, WSB800U) for 45s. Different amounts 
of NaOH (1%, 2%, 4% and 8%, w/w) were added into the mixtures. The mixtures 
were boiled for 1h with stirring. Then the mixtures were cooled rapidly under 
cold water followed by centrifugation (6000g, 20min), and then the extraction 
supernatants were recovered and weighed for further precipitation.  
The ethanol precipitation method was developed from Li et al. (2015). The 
600ml AXs-containing supernatants were mixed with 400µl proteinase. This 
solution was allowed to react at 60°C for 1h to remove protein. Then the solution 
was placed in boiling water bath for 15min to inactivate the proteinase. Then, the 
solution was centrifuged at 6000g for 20min. After centrifugation, the 
supernatant was collected and mixed with 70% (v/v) ethanol (1.4L). The 
mixture was kept at 4°C overnight. Then the mixture was centrifuged at 6000g 
for 20min. After centrifugation, the precipitate was collected and washed twice 
with 20ml aliquots of ethanol. Then the precipitate re-suspended in 20ml 
acetone and washed for 1min. After that, the precipitate was dried in an oven 
overnight at 45°C to obtain alkaline extracted AX sample (AEAX). The AEAXs 
were milled using an analytical mill (IKA A11 Basic, Guangzhou, China, 50/60Hz, 
160W) and weighed.  
 2.2.2 Modification process of the extracted arabinoxylans  
3g AEAXs (8% NaOH extracted) were mixed with 72g distilled water so that 
the ratio of AEAX to mixture was 1/25 (w/w). Three different 
endo-1,4-β-xylanase products (E-XYLNP, P-BG, O-VR) were used to modify the 
AEAX and the treatment time were 24h and 48h. 0.03g of each enzyme (400ppm 
enzyme of 75g mixture was 0.03g) was added in the mixture. The optimum pH 
and temperature of enzymes were according to studies of Malunga and Beta 
(2015), Li et al. (2015) and the manufacturer instructions. The conditions of each 
enzyme treatment were set as pH 6.0, 50°C and 24h/48h for E-XYLNP treatment; 
pH 4.5, 50°C and 24h/48h for P-BG treatment; pH 4.0, 50°C and 24h/48h for 
O-VR treatment. After 24h/48h enzymatic treatments, the mixtures were placed 
in a boiling water bath for 15min to inactivate the enzymes. The modified AXs 
were collected using a rotary vacuum evaporation procedure. Most of the water 
in the mixture was evaporated by rotary vacuum evaporation and then the 
residue was placed in a 45°C oven overnight for drying. The dried residues were 
milled using an analytical mill and weighed, which were enzyme modified AEAX 
samples so that were named as E-AEAXs.  
 
2.2.3 Analysis of extraction yields of arabinoxlyans  
A standard curve of xylose was constructed using the method described by S. 
G. Douglas (1980) for determination of the xylose content of corn bran and AXs’ 
extraction supernatants, which, in turn, was used to calculate the content of AX in 
the samples based on their A/X ratio as tested in mono-sugar composition 
analysis, which using the equation according to Li et al. (2015): 
AX%=Xylose%×(1+A/X). Then the AX content in extraction supernatant was 
used to calculate the extraction yield of AX from raw material based on the 
weight of the supernatant and raw material. Thus, the calculation equation as 
followed:   
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2.2.4 Analysis of sugar compositions of arabinoxylans 
 The mono-sugar compositions of AX samples were analysed by following a 
method developed from Li et al. (2015). One ml of 1M H2SO4 was added to 20mg 
dried AX sample. The mixture was hydrolysed for 2 h at 100°C in a glycerin bath. 
The mixture was transfer to volumetric flasks and diluted 20 fold (1mg/ml) 
using HPLC grade water. The pH value of diluted solution was adjusted to 6.5-7.2 
with 1M NaOH. The solution was then filtered through a 0.45μm nylon 
membrane and transferred separately to 1ml glass shell vials for HPLC analysis. 
Mobile phase (Buffer) was HPLC water. The pump was Shimadzu LC-10ADvp 
Pump. Isocratic elution model was used in the HPLC test. Flow rate of mobile 
phase was set as 0.5 ml/min. Running time of HPLC was 30min per sample. 
Detector was JASCO RI-2031 Refractive index (RI) Detector. Columns were 
SUPELCOGEL Pb (5cm×4.6mm) and Phenomenex ThermaSphere TS-130. 
Temperature of treatment was 85°C. All analyses were conducted in triplicate, 
and p-values were required to be within a 5%. 
 
2.2.5 Analysis of molecular weight distributions of arabinoxylans 
Size exclusion high-pressure liquid chromatography (HPLC-SEC) with a 
refractive index (RI) detector was used to determine the molecular weights and 
size distribution of dried AXs samples, which the Mw determination method was 
according to Li et al. (2013) and Li et al. (2015).   
Mobile phase (Buffer) prepared by 17g NaNO3 and 0.65g NaN3, which 
dissolved in HPLC grade water and transferred to a 2,000ml flask, then topped up 
with HPLC grade water. Eight pullulan standards with molecular weights in the 
range 5,000-800,000Da were used to construct a standard curve. The standard 
samples were dissolved in the mobile phase to yield 0.5mg/ml solutions, and left 
overnight under gentle stirring. They were then filtered through a 0.45μm nylon 
membrane and transferred to 1ml glass shell vials. The dried AXs samples were 
dissolved in the mobile phase to make 2mg/ml solutions and left overnight under 
gentle stirring. Then they were filtered through a 0.45μm nylon membrane and 
transferred to 1ml glass shell vials for HPLC-SEC analysis. 
The pump of Shimadzu LC-10ADvp was used in HPLC-SEC devices. Isocratic 
elution model was used in the HPLC-SEC test. The detector was JASCO RI-2031 
Refractive index (RI) Detector (Jasco Corporation, Tokyo, Japan). Columns of 
BioSep-SEC-S 4000 and BioSep-SEC-S 3000 (Phenomenex, Macclesfield, UK) 
were used to determine the Mw distribution of the AXs. Two continuous columns 
connected in series (start from BioSep-SEC-S 4000) that were used to improve 
the peak shape of the AXs samples. Running time was 60min per sample and flow 
rate was 0.6 ml/min. All analyses were conducted in duplicate, and values were 
required to be within a 5%.  
 
2.2.6 in vitro study  
2.2.6.1 Human U937 Cell culture 
 The complete cell culture medium was prepared using the medium of 
RPMI-1640 with L-glutamine (Lonza, Belgium) with 10% foetal bovine serum 
(FBS) and 2% penicillin-streptomycin (P/S). The Human U937 macrophage cell 
line was grown in complete culture medium using sterile tissue culture flasks. 
The cells were cultured in a cell incubator at 37°C with 5% CO2 in air atmosphere. 
The cells were subcultured every 2 days. 
 
2.2.6.2 Polysaccharides medium preparation of in vitro study 
 The E-AEAX sample from the enzymatic modification (O-VR 48h) of corn 
bran, the AEAX sample from the alkaline extraction (NaOH 8%) of corn bran and 
LPS were solubilised in a culture medium (the RPMI-1640 medium with 5% FBS) 
overnight. Then it sterilised using a 0.45μm sterile filter. The completely 
solubilised samples were diluted to yield a series of concentrations (5μg/ml, 
50μg/ml, 500μg/ml, 1000μg/ml) for cell culture treatments. The samples were 
stored at 4°C in sterile Falcon tubes (Fisher Scientific, UK).  
 
2.2.6.3 Toxicity test of corn bran AXs 
Cell growth and viability of U937 cells following treatment with AX samples 
and LPS were assessed by cell count and trypan blue uptake. Trypan blue is one 
of the dye exclusion procedures for viable cell counting. This method is based on 
the principle that viable (live) cells with intact cell membranes are able to 
exclude trypan blue staining, whereas nonviable (dead) cells can take up trypan 
blue and are shown to be a blue colour under a microscope (Kim et al. 2005; 
Palama et al. 2011).  
U937 cells were cultured in the complete culture medium until they reached 
≥90% viability. Then, the U937 cells were centrifuged (1000g for 10min) and 
resuspended in RPMI-1640 medium with 10% FBS such that the density of live 
cells was set at 1×106/ml. 100μl cell suspension was pipetted in each well of a 
96-well microplate. The AXs and LPS mediums with three high concentrations 
(50, 500 and 1000μg/ml) were prepared sterile and pre-warmed up to 37°C and 
then 100μl of each concentration was added to six wells of containing cells and 
mixed thoroughly. The microplates were then placed in an incubator (37°C, 5% 
CO2) for 24h. After 24h incubation, 40μl of cell fluid was pipetted from each well 
into a tube and a similar volume, 40μl, of trypan blue (Sigma-Aldrich, UK) was 
added to each tube. The account of stained cells (nonviable cells) and not stained 
cells (viable cells) with trypan blue in each sample were counted using a TC10 
automated cell counter (Bio-Rad, UK). The viability of cells was confirmed via 
number of viable cells by total cells (total number of viable and nonviable cells). 
 
2.2.6.4 Nitric oxide stimulation assay 
This assay is used to evaluate the ability of AX samples and LPS to induce NO 
production in the cell line U937 using Griess reagent. In the presence of oxygen 
and water, NO interacts with itself to generate other reactive nitrogen oxide 
intermediates and ultimately decomposes to form NO2− (Dawson and Dawson 
1995). The Griess’ reagent was used for quantitative determination of NO2-, a 
stable oxidative end product of the antimicrobial effector molecule, nitric oxide 
(Fiddler 1977). In this study, Griess’ reagent was freshly prepared immediately 
before use in the NO stimulation assay according to the methodology of Dawson 
and Dawson (1995) and Griess (1879). Griess reagent is made up by two 
components. Component A is 37.5mmol/L sulphanilamide with deionized water 
in 6.5mol/L HCl by 1:1 (v/v). Component B is N-1-napthylethylenediamine 
dihydrochloride (NEED) in deionized water at 12.5mmol/L. NEED and 
sulphanilamide were purchased from Sigma Aldrich, UK. Various immune cell 
lines including macrophages have been shown to produce elevated levels of NO 
as a response to immune-stimulants such as LPS and cytokines (Jeong and Kim 
2002). So LPS was used as a positive control.  
The U937 cells were centrifuged (1000g for 10min) and resuspended in 
RPMI-1640 with 10% FBS such that the density of live cells was set at 1×106/ml. 
50μl of cell suspension was pipetted in each well of a 96-well microplate. 
Polysaccharide samples in RPMI-1640 with 5% FBS were prepared sterile at 
various concentrations and pre-warmed in a water bath (37°C), and then 50μl of 
each was added to the appropriate wells of containing cells and mixed thoroughly. 
The 50μl RPMI-1640 with 5% FBS medium was added to well containing 50μl 
live cells as a negative control. The LPS at various concentrations was used as 
positive control samples. All experimental samples were added to the cells in 
triplicate wells. After the addition of AXs, LPS and negative control, the 
microplates were incubated (37°C, 5% CO2) for 24 hours before NO assessments 
were made.  
 A nitrite standard reference curve was used to quantitatively determine the 
concentration of nitrite production in the experimental wells. Nitrite standards 
were prepared using sodium nitrite (Sigma Aldrich, UK) diluted in medium 
(RPMI-1640 with 10% FBS) at a range of concentrations (0, 0.1, 1.0, 10, 25, 50, 
80 and 100μM). Then 100μl of each standard was added into each well and 
incubated (37°C, 5% CO2) for 24h, alongside the AX sample treatments. All 
experimental standards were added to the cells in triplicate wells.  
 After 24h incubation, Griess’ reagents (Component A and Component B) 
were warmed up to 37°C before use. 50μl of Component A was added to each 
well and mixed. The microplate was incubated at room temperature for 10 
minutes. 50μl of Component B was then added to each well and mixed and 
incubated at 4°C for 20 minutes. The absorbance of each well was then measured 
at 540nm using a microplate reader (Synergy HTX Multi-Mode Reader, Biotek, 
UK).  
 
2.2.7 Statistics  
 The results, unless otherwise stated, were performed in triplicate and 
checked using analysis of one-way ANOVA. A value of p≤0.05 was chosen as the 
criterion of statistical significance. The data were expressed as means±standard 
error (SE). 
3. Results and Discussions 
3.1 Extraction and modification recovery yield of arabinoxylans  
The total AXs content was determined as 25.98±0.31% of corn bran (dry 
matter basis). The alkaline extraction investigated here has been developed from 
the previous studies of L.W. Doner and Hicks (1997a) and L.W. Doner et al. 
(1998). The intention being to investigate the effect of NaOH concentration on 
corn bran AXs extraction yields. Figure 1 shows significant effects of the alkaline 
treatment on AXs extraction yield of corn bran (dry matter basis). Compared to 
water extraction, alkaline extraction is highly efficient. The AXs extraction yield 
increased from 2.58% up to 20.84% with increasing NaOH concentration from 1% 
to 8%. The AX’s recovery rate reached about 80% of the total AX using 8% NaOH. 
The major reasons for the increased AX yield achieved using alkaline treatment 
can be explained as alkali (OH-) is more easy to disrupt the hydrogen bonds 
between AXs and other components compared with water treatment, and may 
also disrupt some covalent bonds, such as ester linkages, thus, loosening up the 
cell wall matrix, consequently solubilising part of the AXs materials, including 
AXs, from the cell wall of corn bran (Fincher and Stone 1986).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Effects of NaOH concentrations on AX extraction yields from corn bran 
(dry matter basis) 
 
The extraction yields are presented as mean with SD bar in the figure. Experiments were conducted in 
triplicate. NaOH (0%) means water extraction without NaOH treatment.   
 
Following extraction with 8% NaOH, the AEAX sample was modified with 
three types of endoxylanase treatments, including P-BG, E-XYLNP and O-VR from 
Thermomyces lanuginosus, Neocallimastix patriciarum and Penicillium 
funiculosum respectively. As shown in Table 1, high recovery yields (≈88%) of 
AXs from AEAX sample was achieved from enzyme treatments. In addition, there 
is no significant difference in the recovery yield of E-AEAX between different 
endoxylanase treatments and/or different treatment times of the 24h and 48h 
(p-values>0.05).  
 
Table 1 The recovery yield of E-AEAXs using three types of endoxylanase 
          Enzyme 
Treatment Time 
Enzyme treatments 
P-BG E-XYLNP O-VR 
24 h 88.02±0.35% 88.01±0.14% 88.00±0.28% 
48 h 88.05±0.34% 88.07±0.14% 87.95±0.07% 
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3.2 Characterisation of the alkaline extracted AXs (AEAX) and the enzyme 
modified AXs (E-AEAXs) of corn bran 
3.2.1 Monosaccharide compositions of the AEAX and the E-AEAXs  
As shown in Table 2, the AEAX sample extracted from corn bran using 8% 
NaOH had an A/X ratio of 0.82, which is consistent with the results from a 
previous study (L.W. Doner et al. 1998), which reported that the A/X ratio for 
alkaline extracted AXs of corn bran was 0.82.  
The monosaccharide compositions of E-AEAXs modified for 24h and 48h by 
various endoxylanases (E-XYLNP, P-BG and O-VR) are presented in Table 2. The 
difference in A/X ratios (0.82-0.89) between AEAXs and E-AEAXs indicate that 
there is a higher degree of branching on the β-1,4-D-xylopyranose backbone of 
the E-AEAXs than that of AEAXs. There appears to be no obvious difference in 
monosaccharide compositions between AEAX samples and AEAX modified by the 
three different endoxylanase preparations of the same enzymes. This means that 
the enzyme treatments have no significant effect on the degree of substitution of 
AEAX.  
 
Table 2 The monosaccharide compositions of the AEAX and E-AEAXs 
Samples 
a
 
Mono-sugar compositions  
Ara(%) Xyl(%) Glu(%) Gal(%)     A/X  
AEAX (8% NaOH) 38.3±0.45  46.97±0.63  /  14.73±0.44 0.82 
24 hours enzyme treatment (E-AEAXs 24h) a 
E-XYLNP  39.10±1.65 47.1±0.95  / 14.53±0.99 0.83 
P-BG  40.04±1.00 45.57±0.92 / 14.50±0.31 0.88 
O-VR  39.17±2.12 47.07±1.56  / 13.98±0.48 0.83 
48 hours enzyme treatment (E-AEAXs 48h) a 
E-XYLNP  41.16±1.32 45.3±0.67  / 14.53±1.03 0.89 
P-BG 39.88±0.84 45.21±0.77  / 14.91±0.12 0.88 
O-VR  38.84±2.30 47.29±1.56  / 13.87±0.89 0.82 
a: (E-XYLNP 48h/24h; P-BG 48h/24h; O-VR 48h/24h) means modified AEAXs using one of those three 
different enzymes for 48 hours or 24 hours. The proportion of each monosaccharide in AX samples is 
presented as mean + SD and all experiments were conducted in triplicate. 
 3.2.3 Effects of various enzyme treatments on molecular weight distributions of 
extracted arabinxylans 
As shown in Table 3, the largest proportion of AEAX (84%) is mainly in range 
1 (100KDa to 794KDa). After 24 h treatment with the three enzyme preparations 
(P-BG 24h; E-XYLNP 24h and O-VR 24h), E-AEAXs portion (17-19%) in the small 
Mw range 2 (10KDa to 100KDa) slightly increased compared with that of AEAX 
portion (13.7%) in range 2. E-AEAXs portion (78.1-79.7%) in the large Mw range 
1 (100KDa to 794KDa) generally decreased compared with AEAX portion (83.5%) 
in range 1. As shown in Figure 2, the Mw distributions of E-AEAXs showed a 
small change in Mw range of 1×104.5 to 1×105.5Da. There mainly comprises a 
peak in large Mw range 1 (501.187KDa; log10Mw≈5.7; DP≈3797). However, AEAX 
subjected to longer enzymatic treatments 48 hours had a clearly changed Mw 
(Figure 3). The Mw distribution curve of the E-AEAXs contain two main peaks in 
small Mw range (3.715KDa；log10Mw≈3.6; DP≈28) and the other peak in large 
Mw range (around 501.187KDa). This longer exposure to the enzymes reduced 
the proportion of large Mw AX in range 1 by approximately 20-32% and 
increased the proportion of small Mw AX in ranges 3 and 4 by 17-30% (Table 3). 
Specifically, after 48 hours the treated samples showed reduced values of 63.70% 
(P-BG), 54.81% (E-XYLNP) and 51.23% (O-VR) compared to the AEAX level of 
83.53% in the high Mw range 1 (100KDa to 794KDa), and an increased 
proportion in the lower Mw ranges from 2.82% to 17.83-24.46% in range 3 and 
from 0 to 2.19-8.64% in range 4. For the three different enzymes, the sample of 
E-AEAX using O-VR treatment for 48 h (O-VR 48h) showed the largest increase in 
the proportion of AX with small Mw ranges 3 and 4 compared to that of AEAX 
(Table 3). Specially, 48h O-VR treatment changed the proportion of large Mw of 
AEAXs in range 1 (100KDa to 794KDa) from 83.53% to 51.23%, whereas the 
proportion of low Mw material in ranges 3 and 4 (0.1KDa to 10KDa) increased 
from 2.82% to 33.1%.     
 
 
 
 
Table 3 The proportions of AEAX and E-AEAXS in different ranges of molecular 
weight  
Samples 
Mw ranges of AXs d 
Range 1: 
1×105-105.9(Da) 
Range 2: 
1×104-105(Da) 
Range 3: 
1×103-104(Da) 
Range 4: 
1×102-103(Da) 
AEAX a 83.53% 13.65% 2.82% / 
24 hours b (E-AEAXs 24h) 
P-BG  78.08% 19.19% 2.73% / 
E-XYLNP 79.67% 17.53% 2.80% / 
O-VR 79.73% 17.32% 2.95% / 
48 hours c (E-AEAXs 48h) 
P-BG 63.70% 16.29% 17.83% 2.19% 
E-XYLNP 54.81% 14.39% 23.44% 7.36% 
O-VR 51.23% 15.66% 24.46% 8.64% 
a: The AEAX samples indicates extracted AXs using 8% NaOH treatment; b: Those three samples 
means enzyme modified AEAXs (E-AEAXs) using the different types of endoxylanases (P-BG, E-XYLNP 
and O-VR) for 24 hours; c: Those three samples means enzyme modified AXs (E-AEAXs) using the 
different types of endoxylanases for 48 hours; d: The percentage of AXs in different Mw range were 
analysed using the LC Data Analysis (SHIMADZU Corporation) and Microsoft Excel. The overall Mw 
distribution ranges of the AXs are from 0.1KDa to 794KDa. Each molecular weight distribution is 
divided into four molecular weight ranges.   
 Figure 2 The molecular weight distributions of E-AEAXs treated using three different 
types of enzyme for 24 hours treatment  
 
 
 
 
 
 
 
 
 
Figure 3 The molecular weight distributions of E-AEAXs treated with 48 h treatment 
of three types of endoxylanase  
 
 
According to the results, the treatment time is a significant factor in the Mw 
modification of AEAX using the endoxylanase. AXs have a tendency to form 
macrostructures in aqueous solutions through chain aggregation and physical 
entanglements (Warrand et al. 2005). The molecular size of AX is a key factor for 
its behaviour in solution. The high Mw AXs may more easily form aggregations 
and exhibit weakly elastic properties in solution than the low molecular weight 
fractions (Izydorczyk and Biliaderis 1992a). From Table 3, the Mw of AEAX 
fraction consists largely (>80%) of high molecular weight material (100KDa to 
794KDa). Thus, some of AEAXs may form macrostructures that inhibit the AX 
behaviour in the aqueous solution. Family GH 11 endoxylanases have a β-jelly 
roll structure and are considered to be able to pass through the pores of the xylan 
network owing to their smaller molecular sizes (Juturu and Wu 2012). When the 
network of AEAX becomes more tightknit via physical entanglements, this would 
form a barrier to the endoxylanase，preventing hydrolysis of the xylan chain of 
the AXs. In this case, a longer treatment time (48h) is necessary to degrade the 
molecules of entangled AXs. Thus, improving the solubility and reducing the 
impact of AEAX aggregation should be considered when developing the 
modification process of AEAXs in future studies. In addition, Shiiba et al. (1993) 
investigated the effect of endoxylanase on AXs Mw modification and showed that 
the reduction in Mw of AXs might depend on the proportion of 
L-arabinofuranosyl branches. This study compared the hydrolysis effect of 
endoxylanase on two different AXs from wheat bran with different degrees of 
branching, and found that the highly branched AX (A/X=1.07, 79% substituted 
xylose residues) was much more difficult to modify the Mw than the AX with a 
relative low degree of branching (A/X=0.57, 62% substituted xylose residues). 
According to Kusakabe et al. (1983), the xylanase is specific for the hydrolysis of 
xylose chains that are devoid of branches of L-arabinofuranose residues or 
2-O-β-D-xylopyranosyl-L-arabinose. Similarly, Biely et al. (1997) reported that 
AXs with a low degree of branching are more susceptible to endoxylanase action. 
In the present study, the A/X ratio of AEAX was 0.82, which is a high degree of 
branching may explain why the Mw modification process using enzyme 
treatments was difficult and required a long treatment time.  
In addition, Comparison of the abilities of the three types of endoxylanases 
respectively isolated from Thermomyces lanuginosus, Neocallimastix patriciarum 
and Penicillium funiculosum in modifying the Mw of AEAX from corn bran, it was 
shown that the most effective one is O-VR from Penicillium funiculosum. From 
previous studies, it is important to note that due to the differences in substrate 
specificities, binding modules and enzyme production technology, different 
xylanases may have different activity in reducing Mw of xylans (Shoseyov et al., 
2006; Driss et al., 2013; Garg et al. 2010).  
 
3.3 Immunomodulatory activity of arabinoxylans  
3.3.1 Effects of arabinoxylans treatment on growth and viability of U937 cells 
The Trypan blue exclusion assay with cell count was used to assess cell 
growth and viability of the human macrophage U937 in presence of the AXs and 
LPS at various concentrations are shown in Figure 4: a-c. Figures 4 b and c 
demonstrate that the viable and total cell counts for AXs (50, 500, 1000μg/ml) 
treated U937 macrophages are not significantly different compared to control 
(untreated cells) (p-values>0.05). Hence, AEAX and E-AEAX have no stimulatory 
effect on the growth of U937 cells over the period of 24h. In addition, the viability 
of cells with AX treatments was typically over 90%, suggesting that AEAX and 
E-AEAX also have no effect on U937 cell survival over the period of 24hrs. 
Polysaccharides extracted from plants have received considerable attention in 
bioscience due to their wide immune-modulatory activities and low toxicity 
(Schepetkin and Quinn 2006). The present study indicated that the AX samples 
have no inhibitory effects on the viability and cell growth of the human U937 
macrophage, even at a high concentration of 1000μg/ml.  
However, as shown in Figure 4 (a), the cell counts of viable and total U937 
cells were reduced significantly after treatment with 500 and 1000μg/ml of LPS 
compared with that of untreated control (p-values<0.01). In contrast, this 
inhibitory effect on cell growth did not appear at relatively low concentrations 
(e.g. 50μg/ml) of LPS treatments. This suggests that high concentrations of LPS 
may have an inhibitory effect on U937 cell growth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Effects of AXs and LPS on the viability of U937 cells  
a. 
 
b.  
 
c. 
 
a-e: the U937 cells were treated with the LPS, AEAX and E-AEAX for 24hrs; The count of viable (live) and 
total (viable and unviable) cells was confirmed using the trypan blue exclusion method; The solid line 
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‘—‘ indicates the viable cell count of the control and the dotted line ‘---‘ indicates the total cell count of the 
control; The viability: viable cell count/total cell count; the average viable cell count after treatment was 
compared with the cell count of the control (without AXs or LPS treatment) using the Student’s t-test; The 
symbol *: p-value < 0.01; The cell counts are presented as mean + SEM of six copies samples from 
experiment. 
According to previous studies, research has indicated that LPS inhibits and 
blocks macrophage proliferation depending on the incubation time and dosage 
(Muller-Decker et al. 2005; Vadiveloo et al. 1996; Vairo et al. 1992). The 
inhibitory effect of LPS on cell proliferation is tightly regulated through a 
complex network of cytokines. For example, Vadiveloo et al. (2001) found that 
bacterial LPS had an inhibitory effect on cell proliferation in mouse 
marrow-derived macrophages. They found LPS inhibited the expression of cyclin 
D1, which is an essential protein for proliferation in many cell types. In addition, 
the viability of cells with LPS treatments was typically over 90%, suggesting that 
LPS (50-1000μg/ml) has no effect on U937 cell survival over 24hrs. 
 
3.3.2 Effects of arabinoxylans with different molecular structure on NO 
production by U937 cells 
Corn AEAX and E-AEAX with different Mw distributions were also tested and 
compared in terms of their ability to induce NO secretion in U937 cells. Firstly, 
over the concentration range from 5 to 1000μg/ml, Table 4 clearly shows that the 
two AXs samples (AEAX and E-AEAX) treatments both significantly elevated NO 
production by U937 cells after a 24h incubation period compared with the 
untreated control (p<0.05). This result is consistent with previous studies, which 
found that AXs from various cereal sources were able to stimulate the production 
of NO in murine and human macrophage cells (Ghoneum and Matsuura 2004; 
Nagata et al. 2001；Li et al. 2015). Secondly, the LPS was used as a positive control 
and significantly stimulated NO secretion at all concentrations (Table 4) 
compared to the untreated control. However, at 500 to 1000μg/ml of LPS, the 
amount of NO produced by the U937 cells significantly decreased (p<0.05) 
compared to lower concentrations of LPS, mirroring the substantial inhibitory 
effect on cell growth and viability at this concentration (Figure 4 a). 
Table 4 NO production by U937 cell after 24h treatment of AEAX, E-AEAX and 
LPS       
Samples Concentrations of AXs and LPS (μg/ml) Untreated 
Control 5 50 500 1000 
LPS 70.35±1.32 
* 
71.79±2.34 
* 
64.60±1.09 
* # 
56.51±0.01 
* # 
46.05 
±1.95 
E-AEAX 67.30±1.72 
* @ 
67.66±2.381 
* @ 
64.78±2.486 
* 
63.34±1.26 
* # $ 
AEAX 57.59±1.49 
* $ 
61.01±2.27 
* $ 
65.50±1.949 
* # 
66.94±1.86 
* # $ 
The NO2- concentration (mean + SEM) is an indication of NO production in U937 cells; The symbol * 
indicates NO production significantly increased (p<0.05) compared to the untreated control; The 
symbol # indicates NO production significantly changed (p<0.05) as the sample dosage 
progressively increased; The symbol @ indicates NO production with E-AEAX treatment was 
significantly different to that with AEAX at that specific concentration (p-<0.05); The symbol 
$ indicates NO production with AEAX or E-AEAX treatment was significantly different to the 
treatment with LPS at that specific concentration (p-<0.05). The p-values were calculated by 
one-way ANOVA using SPSS.19 and experiments were conducted in triplicate. 
 
Furthermore, Figure 5 indicates there is an obvious dose-response effect for 
each of the three test samples but the effective range over which they work is 
different. The estimated optimum doses for LPS and E-AEAX treatments are in 
the same range 5-50µg/ml whilst the optimum for AEAX treatment should be 
above 1000µg/ml. AEAX had generally lower NO production response compared 
to E-AEAX and LPS at concentration below 50µg/ml. Thus, the optimum dose 
ranges of AEAX and E-AEAX were significant different. According to the Mw 
distributions of E-AEAX and AEAX in Table 3, 33.1% of E-AEAX had Mw ranging 
from 158Da to 10KDa (the ranges 3 to 4) whereas AEAX only contained 2.82% 
AX in this range. In addition, the branch degree (A/X) of E-AEAX and AEAX were 
the same value of 0.82 and the monosaccharide composition shows no glucose 
component and a similar proportion of galactose content in these two AX 
samples. Therefore, when activating NO synthesis by U937 cells, the Mw 
distribution of AX is considered a determinant for their optimum dose, thereby 
affects its immune-modulatory activity.  
Corn bran AX with Mw at the range of 0.1KDa to 10KDa appears the most 
biologically active. Molecular structure of AX has already been reported to have 
an effect on some of their physicochemical properties in solution including 
tertiary conformation of AX chain in solution, viscosity of the solution and elastic 
properties of the solution (Izydorczyk and Biliaderis 2007; S. Zhang et al. 2015). 
Therefore, it is reasonable to conclude that molecular structure, combined with 
these physicochemical properties of AX may confer immune-modulating 
activities. Results of in vitro assessments in this study indicate potential 
underlying mechanisms of the structure-activity relationship of AXs. 
 
Figure 5 Effect of AEAX, E-AEAX and LPS treatments on NO production by U937 
cells 
 
 
3.3.3 Consequences of AX-induced NO stimulation for human health 
NO production by immune cells can be thought of as a signal of 
immunomodulation, and has been used for assessing the immunomodulatory 
activity of examined samples in previous studies (Fang et al. 2012; Ghoneum and 
Matsuura 2004; W. Li et al. 2015). The inhibition of tumour cell growth and/or 
induction of tumour cell death by activated macrophages was one of major 
functions of NO in the immune system (Nathan 1992). A number of studies have 
reported the mechanisms by which macrophage-derived NO can trigger 
cytostasis or kill tumour cells in vitro, such as inhibition of enzymes essential for 
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tumour growth (e.g. enzymes of the respiratory chain, cis-aconitase, 
ribonucleotide reductase arginase, ornithine decarboxylase); cell-cycle arrest via 
down regulation of cyclin D1; and induction of tumour cells sensitization for 
TNF-induced cytotoxicity (Bauer et al. 2001; Nathan 1992; Xie et al. 1996). In 
addition, NO can form a number of oxidation products such as NO2, NO2- and 
N2O3 because of its highly reactive free radical structure (Cai et al. 2015), which 
comes into play at macrophage-mediated immune defence against numerous 
pathogens in infection (Ekman et al. 1999; Rodrigues et al. 2005; Yan et al. 1997).  
In the present investigation, NO secretion by U937 cells after stimulation 
with the AXs samples may reflect on their potential to modulate NO-based 
strategies for tumour treatment and pathogen-mediated immune responses for 
infection treatment. In addition, NO production by macrophage also was 
reported that has inmmunoregulatory functions including modulation T cell 
response, suppression of anti-inflammatory effects and regulation of leukocyte 
recruitment (Bogdan 2000). Thus, the NO modulation activity of AXs may be able 
to apply to regulate the immune system response, thereby maintaining human 
health. Furthermore, the investigation of structure-activity relationship of AX 
could be useful in improving the immunomodulatory activity of AXs.  
4. Conclusions 
According to the results form enzyme modification processes of corn bran 
AXs, treatments of three different endoxylanases appear to modify the Mw 
distribution of the AX extracts obtained but did not obviously change the ratio of 
arabinose and xylose observed and other monosaccharide components. In the 
process of enzyme modification, the enzyme treatment time is a significant factor 
in the Mw modification of AEAX using the endoxylanase. Compared with 
non-modified AXs, the molecular weights of the modified AXs were obviously 
reduced from a high Mw range (100KDa to 794KDa) to a low Mw range (0.1KDa 
to 10KDa).  
The AX extracts from corn bran were tested in a model in vitro systems by 
human macrophage cell line U937. It was observed that the AX extracts 
significantly elevated NO secretion by the U937 cells compared with the 
untreated control (p<0.05), which indicate potential immunomodulation 
properties for improving immune function and reducing the risk of infection and 
cancer. Furthermore, the in vitro study demonstrates that the macrophage 
stimulatory effects of AXs are significantly influenced by their Mw distributions 
and concentrations. Analysis of the relationship between the molecular 
structures and the immune stimulatory activity of AX samples in this study 
suggests differences in the stimulatory effect on NO secretion are closely 
associated with the modified AXs (E-AEAX) which have a much higher 
proportion of low Mw AXs than the non-modified AXs (AEAX). Thus, Mw 
distribution of AX is considered to be a significant determinant of their optimum 
doses of immune-modulatory activity.  
The results of in vitro assessments should be useful in further understanding 
the mechanisms of the structure-activity relationship of AXs. In addition, further 
study may also need to further investigate the mechanism underlying effect of AX 
on the NO pathway in vitro.  
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